Items related to PERSPECTIVES IN ANTIINFECTIVE THERAPY. (Current Topics...
PERSPECTIVES IN ANTIINFECTIVE THERAPY. (Current Topics in Infectious Diseases and Clinical Microbiology. Volume 2) (German Edition) - Softcover
Synopsis
Pharmaceutical research has a long-standing tradition in Bayer since the estab- lishment of a Pharmaceutical Department 25 years after the foundation of the Farbenfabriken of Friedrich Bayer & Co. in the city of Elberfeld, Germany. In 1888 one of the first antipyretic drugs, phenacetin, was synthesized. A mile- stone was marked by the discovery and launch of Aspirin (TM) in 1899, the most widely used and appreciated drug since then. The success of Bayer 205 (Germanin TM) in the treatment of sleeping sickness 1ed not only to the worldwide recognition of Bayer as a pharmaceutical com- pany but also to intense research into anti-infective therapy. The antimalarial drugs Atebrin TM, Plasmochin (TM) and Resochin (TM) were the first of a whole series of significant contributions and even breakthroughs in the therapy of infections. The advances and the success of antibacterial therapy was heralded by the discovery of the antibacterial activity of the sulfonamides by Domagk, Klarer and Mietsch. The first drug of this class of compounds, Prontosil(TM), opened the new era of therapeutic control of bacterial infections. In 1939 Domagk received the Nobel Prize for Medicine for this breakthrough. A furt her breakthrough in the chemotherapy of the scourge of tuberculosis was achieved in 1946 by Domagk and his colleagues Behnisch, Mietzsch and Schmidt with the development of Conte ben TM, followed shortly afterwards by the discovery of isoniazid (Neoteben TM) by Domagk, Offe and Siefken.
"synopsis" may belong to another edition of this title.
- PublisherVieweg+Teubner Verlag
- Publication date1989
- ISBN 10 3528079797
- ISBN 13 9783528079796
- BindingPaperback
- Number of pages308
- EditorJackson G.G.
Buy New
Learn more about this copy
US$ 61.49
Shipping:
FREE
Within U.S.A.
Top Search Results from the AbeBooks Marketplace
Stock Image
PERSPECTIVES IN ANTIINFECTIVE THERAPY. Current Topics in Infectious Diseases and Clinical Microbiology, Volume Two.
Seller: Zubal-Books, Since 1961, Cleveland, OH, U.S.A.
Seller rating 5 out of 5 stars
Condition: Good. *Price HAS BEEN REDUCED by 10% until Monday, Sept. 23 (weekend sale item)* 310 pp., paperback, ex library, else text clean & binding tight. - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country. Seller Inventory # ZB611390
Quantity: 1 available
Stock Image
PERSPECTIVES IN ANTIINFECTIVE THERAPY. (Current Topics in Infectious Diseases and Clinical Microbiology. Volume 2) (German Edition)
Seller: Phatpocket Limited, Waltham Abbey, HERTS, United Kingdom
Seller rating 5 out of 5 stars
Condition: Good. Your purchase helps support Sri Lankan Children's Charity 'The Rainbow Centre'. Ex-library, so some stamps and wear, and may have sticker on cover, but in good overall condition. Our donations to The Rainbow Centre have helped provide an education and a safe haven to hundreds of children who live in appalling conditions. Seller Inventory # Z1-I-014-00915
Quantity: 1 available
Stock Image
Perspectives in Antiinfective Therapy
Seller: Clivia Mueller, Isernhagen, Germany
Seller rating 5 out of 5 stars
Current Topics in Infectious Diseases and Clinical Microbiology Volume 2. IX. 299 S. Quart. mit Abbildungen. ISBN: 3528079797. Vieweg. Braunschweig. 1989. Mit Gebrauchsspuren/Used condition. Broschur/Softcover. Sprache: englisch/english. Seller Inventory # 2P2650
Quantity: 1 available
Seller Image
PERSPECTIVES IN ANTIINFECTIVE THERAPY. (Current Topics in Infectious Diseases and Clinical Microbiology. Volume 2) (German Edition) [Paperback ]
Seller: booksXpress, Bayonne, NJ, U.S.A.
Seller rating 4 out of 5 stars
Soft Cover. Condition: new. Seller Inventory # 9783528079796
Quantity: 10 available
Stock Image
Perspectives in Antiinfective Therapy: Bayer AG Centenary Symposium Washington, D. C., Aug. 31 Sept. 3, 1988
Seller: Chiron Media, Wallingford, United Kingdom
Seller rating 5 out of 5 stars
PF. Condition: New. Seller Inventory # 6666-IUK-9783528079796
Quantity: 10 available
Stock Image
PERSPECTIVES IN ANTIINFECTIVE THERAPY. (Current Topics in Infectious Diseases and Clinical Microbiology. Volume 2) (German Edition)
Seller: California Books, Miami, FL, U.S.A.
Seller rating 5 out of 5 stars
Condition: New. Seller Inventory # I-9783528079796
Quantity: Over 20 available
Stock Image
Perspectives in Antiinfective Therapy: Bayer AG Centenary Symposium Washington; D. C.; Aug. 31 Sept. 3; 1988
Print on DemandSeller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9783528079796_lsuk
Quantity: Over 20 available
Seller Image
Perspectives in Antiinfective Therapy
Published by
Vieweg & Teubner Verlag Jan 1989, 1989
ISBN 10: 3528079797
ISBN 13: 9783528079796
New
Taschenbuch
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Pharmaceutical research has a long-standing tradition in Bayer since the estab lishment of a Pharmaceutical Department 25 years after the foundation of the Farbenfabriken of Friedrich Bayer & Co. in the city of Elberfeld, Germany. In 1888 one of the first antipyretic drugs, phenacetin, was synthesized. A mile stone was marked by the discovery and launch of Aspirin in 1899, the most widely used and appreciated drug since then. The success of Bayer 205 (Germanin TM) in the treatment of sleeping sickness 1ed not only to the worldwide recognition of Bayer as a pharmaceutical com pany but also to intense research into anti-infective therapy. The antimalarial drugs Atebrin TM, Plasmochin and Resochin were the first of a whole series of significant contributions and even breakthroughs in the therapy of infections. The advances and the success of antibacterial therapy was heralded by the discovery of the antibacterial activity of the sulfonamides by Domagk, Klarer and Mietsch. The first drug of this class of compounds, Prontosil , opened the new era of therapeutic control of bacterial infections. In 1939 Domagk received the Nobel Prize for Medicine for this breakthrough. A furt her breakthrough in the chemotherapy of the scourge of tuberculosis was achieved in 1946 by Domagk and his colleagues Behnisch, Mietzsch and Schmidt with the development of Conte ben TM, followed shortly afterwards by the discovery of isoniazid (Neoteben TM) by Domagk, Offe and Siefken. 312 pp. Deutsch. Seller Inventory # 9783528079796
Quantity: 2 available
Stock Image
Perspectives in Antiinfective Therapy: Bayer Ag Centenary Symposium Washington, D. C., Aug. 31-sept. 3, 1988
Seller: Revaluation Books, Exeter, United Kingdom
Seller rating 5 out of 5 stars
Paperback. Condition: Brand New. 308 pages. German language. 11.00x8.20x0.74 inches. In Stock. Seller Inventory # x-3528079797
Quantity: 2 available
Seller Image
Perspectives in Antiinfective Therapy : Bayer AG Centenary Symposium Washington, D. C., Aug. 31¿Sept. 3, 1988
Seller: AHA-BUCH GmbH, Einbeck, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Pharmaceutical research has a long-standing tradition in Bayer since the estab lishment of a Pharmaceutical Department 25 years after the foundation of the Farbenfabriken of Friedrich Bayer & Co. in the city of Elberfeld, Germany. In 1888 one of the first antipyretic drugs, phenacetin, was synthesized. A mile stone was marked by the discovery and launch of Aspirin in 1899, the most widely used and appreciated drug since then. The success of Bayer 205 (Germanin TM) in the treatment of sleeping sickness 1ed not only to the worldwide recognition of Bayer as a pharmaceutical com pany but also to intense research into anti-infective therapy. The antimalarial drugs Atebrin TM, Plasmochin and Resochin were the first of a whole series of significant contributions and even breakthroughs in the therapy of infections. The advances and the success of antibacterial therapy was heralded by the discovery of the antibacterial activity of the sulfonamides by Domagk, Klarer and Mietsch. The first drug of this class of compounds, Prontosil , opened the new era of therapeutic control of bacterial infections. In 1939 Domagk received the Nobel Prize for Medicine for this breakthrough. A furt her breakthrough in the chemotherapy of the scourge of tuberculosis was achieved in 1946 by Domagk and his colleagues Behnisch, Mietzsch and Schmidt with the development of Conte ben TM, followed shortly afterwards by the discovery of isoniazid (Neoteben TM) by Domagk, Offe and Siefken. Seller Inventory # 9783528079796
Quantity: 1 available